NasdaqGS - Delayed Quote • USD
Bruker Corporation (BRKR)
At close: June 7 at 4:00 PM EDT
After hours: June 7 at 6:21 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 10 | 10 |
| Avg. Estimate | 0.53 | 0.7 | 2.66 | 3.14 |
| Low Estimate | 0.5 | 0.64 | 2.55 | 2.75 |
| High Estimate | 0.56 | 0.78 | 2.81 | 3.59 |
| Year Ago EPS | 0.5 | 0.74 | 2.68 | 2.66 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 9 |
| Avg. Estimate | 792.49M | 874.27M | 3.38B | 3.68B |
| Low Estimate | 759.77M | 838M | 3.29B | 3.51B |
| High Estimate | 807.9M | 895.9M | 3.42B | 3.75B |
| Year Ago Sales | 681.9M | -- | 2.96B | 3.38B |
| Sales Growth (year/est) | 16.20% | -- | 14.00% | 8.70% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.48 | 0.63 | 0.68 | 0.46 |
| EPS Actual | 0.5 | 0.74 | 0.8 | 0.53 |
| Difference | 0.02 | 0.11 | 0.12 | 0.07 |
| Surprise % | 4.20% | 17.50% | 17.60% | 15.20% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.53 | 0.7 | 2.66 | 3.14 |
| 7 Days Ago | 0.53 | 0.71 | 2.68 | 3.17 |
| 30 Days Ago | 0.54 | 0.76 | 2.78 | 3.38 |
| 60 Days Ago | 0.57 | 0.76 | 2.74 | 3.42 |
| 90 Days Ago | 0.57 | 0.76 | 2.74 | 3.44 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 3 | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | 2 | 2 |
Growth Estimates
| CURRENCY IN USD | BRKR | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 6.00% | -- | -- | 9.10% |
| Next Qtr. | -5.40% | -- | -- | 11.50% |
| Current Year | -0.70% | -- | -- | 5.70% |
| Next Year | 18.00% | -- | -- | 12.60% |
| Next 5 Years (per annum) | 12.90% | -- | -- | 11.34% |
| Past 5 Years (per annum) | 20.10% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Stifel: Hold to Hold | 5/20/2024 |
| Maintains | B of A Securities: Buy to Buy | 5/20/2024 |
| Maintains | Goldman Sachs: Sell to Sell | 4/10/2024 |
| Maintains | UBS: Buy to Buy | 3/1/2024 |
| Maintains | UBS: Buy to Buy | 2/15/2024 |
| Maintains | Citigroup: Buy to Buy | 2/14/2024 |
Related Tickers
BIO Bio-Rad Laboratories, Inc.
287.02
-0.69%
CTKB Cytek Biosciences, Inc.
6.00
+0.50%
QDEL QuidelOrtho Corporation
41.67
-2.14%
STE STERIS plc
226.85
-1.57%
PODD Insulet Corporation
191.42
-0.52%
MASI Masimo Corporation
125.46
+0.53%
CNMD CONMED Corporation
76.41
-0.68%
FNA Paragon 28, Inc.
6.74
-5.07%
IART Integra LifeSciences Holdings Corporation
30.80
-1.00%
PEN Penumbra, Inc.
188.95
-3.80%